These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


157 related items for PubMed ID: 7619411

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immunologic characteristics of cytokines in otitis media with effusion.
    Himi T, Suzuki T, Kodama H, Takezawa H, Kataura A.
    Ann Otol Rhinol Laryngol Suppl; 1992 Oct; 157():21-5. PubMed ID: 1416648
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Transforming growth factor-beta expression in otitis media with effusion.
    Cooter MS, Eisma RJ, Burleson JA, Leonard G, Lafreniere D, Kreutzer DL.
    Laryngoscope; 1998 Jul; 108(7):1066-70. PubMed ID: 9665258
    [Abstract] [Full Text] [Related]

  • 9. Complement activation in pediatric patients with recurrent acute otitis media.
    He Y, Scholes MA, Wiet GJ, Li Q, Clancy C, Tong HH.
    Int J Pediatr Otorhinolaryngol; 2013 Jun; 77(6):911-7. PubMed ID: 23537925
    [Abstract] [Full Text] [Related]

  • 10. High concentrations of middle ear antimicrobial peptides and proteins and proinflammatory cytokines are associated with detection of middle ear pathogens in children with recurrent acute otitis media.
    Seppanen EJ, Thornton RB, Corscadden KJ, Granland CM, Hibbert J, Fuery A, Wiertsema SP, Vijayasekaran S, Coates HL, Jacoby P, Currie A, Richmond PC, Kirkham LS.
    PLoS One; 2019 Jun; 14(12):e0227080. PubMed ID: 31877198
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. TH1/TH2 and regulatory cytokines in adults with otitis media with effusion.
    Kariya S, Okano M, Hattori H, Sugata Y, Matsumoto R, Fukushima K, Schachern PA, Cureoglu S, Paparella MM, Nishizaki K.
    Otol Neurotol; 2006 Dec; 27(8):1089-93. PubMed ID: 16988618
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of cytokines present in middle ear effusions.
    Yellon RF, Leonard G, Marucha PT, Craven R, Carpenter RJ, Lehmann WB, Burleson JA, Kreutzer DL.
    Laryngoscope; 1991 Feb; 101(2):165-9. PubMed ID: 1992267
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.